Concerto Biosciences rebuilds microbial communities in, on, and around us to heal our bodies and our planet. Products that rebuild microbial communities do not yet exist because no one can map the vast inter-species interaction networks responsible for community behavior. Concerto’s cofounders invented kChip, the first-ever ultra-high-throughput platform to experimentally measure millions of microbial interactions. Using kChip data, Concerto can map interaction networks that reveal a new class of products it calls “ensembles”—combinations of microbes that work in concert to shepherd damaged microbial communities to health.
Location: United States, Massachusetts, Cambridge
Total raised: $47.54M
Investors 6
| Date | Name | Website |
| 08.11.2022 | M Ventures | m-ventures... |
| - | Taihill Ve... | taihill.vc |
| 15.11.2023 | MassVentur... | mass-ventu... |
| 22.12.2022 | Skylight I... | skylightin... |
| - | Impact Sci... | impactscie... |
| - | Axial VC | axialvc.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.11.2022 | Series A | $23M | - |
| 22.03.2022 | - | $24.54M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 06.02.2023 | Concerto Biosciences Announces Strategic Business Developmen... | Didier Vingadassalom, Ph.D., to Drive New Partnerships as Concerto’s Senior Director, Business Devel... | aithority.... |
| 04.11.2022 | StartUPDATES: New Developments for Healthcare Startups | Carrum Health extended the reach of its bundled cancer care through an alliance with City of Hope, o... | medcitynew... |
| 02.11.2022 | Concerto Biosciences Raises $23M in Series A Funding | Concerto Biosciences, a Cambridge, MA-based biotechnology company, raised $23M in Series A funding. ... | finsmes.co... |
| 02.11.2022 | Concerto Biosciences Raises $23M in Series A | CAMBRIDGE, MA, Concerto Biosciences, a biotechnology company, announced that it raised $23 million... | vcnewsdail... |